BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4734402)

  • 21. Antigen-antibody complexes suppress antibody production by mouse plasmacytoma cells in vitro.
    Abbas AK; Klaus GG
    Eur J Immunol; 1978 Mar; 8(3):217-20. PubMed ID: 350594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of in vivo growth of murine plasmacytoma MOPC-460 by monoclonal anti-idiotypic antibodies directed at distinct idiotypes of the immunoglobulin on the surface of MOPC-460.
    Bridges SH; Le Guern C; Gurgo C
    Cancer Res; 1984 Nov; 44(11):5051-5. PubMed ID: 6488164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symmetry of binding sites of a mouse IgA myeloma protein (MOPC 315).
    Eisenberg R; Plotz P
    Biochemistry; 1978 Oct; 17(22):4801-7. PubMed ID: 569494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cryoprecipitation of murine IgG3 anti-dinitrophenyl (DNP) monoclonal antibodies by anionic DNP-amino acid conjugates.
    Spertini F; Coulie PG; Van Snick J; Davidson E; Lambert PH; Izui S
    Eur J Immunol; 1989 Feb; 19(2):273-8. PubMed ID: 2495223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bivalent hapten-antibody interactions--III. Formation of an unusual polymer by IGA (MOPC 315) upon binding a bivalent hapten.
    Wilder RL; Green G; Schumaker VN
    Immunochemistry; 1975 Jan; 12(1):54-60. PubMed ID: 237832
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor immunity induced by preimmunization with BALB/c mouse myeloma protein.
    Freedman PM; Autry JR; Tokuda S; Williams RC
    J Natl Cancer Inst; 1976 Apr; 56(4):735-40. PubMed ID: 56452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation of antigen-specific lymphocytes. II. Enrichment of hapten-specific antibody-forming cell precursors.
    Haas W
    J Exp Med; 1975 May; 141(5):1015-29. PubMed ID: 165257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of immune response to sheep red blood cells on plasmacytoma MOPC 104 E.
    Ghanta VK; Hiramoto NS; Hiramoto RN
    Cancer Res; 1981 Jun; 41(6):2197-9. PubMed ID: 7237419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosupression of the primary and secondary immune response by an IgM plasmacytoma (TEPC-183).
    Havas HF; Schiffman GD; Fenton M; Goodis A; Braverman S
    Immunology; 1979 Feb; 36(2):191-7. PubMed ID: 35463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrinsic Cotton effects in hapten--carrier and hapten--antibody interactions.
    Reid V; Glaser M; Kennett R; Singer SJ
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1184-7. PubMed ID: 4108175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNP-phycobiliproteins, fluorescent antigens to study dynamic properties of antigen-IgE-receptor complexes on RBL-2H3 rat mast cells.
    Seagrave JC; Deanin GG; Martin JC; Davis BH; Oliver JM
    Cytometry; 1987 May; 8(3):287-95. PubMed ID: 2954795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand binding and physicochemical characteristics of an IgM mouse plasmacytoma ABPC-22.
    Jarvis MR; Voss EW
    Mol Immunol; 1981 Apr; 18(4):261-75. PubMed ID: 6795452
    [No Abstract]   [Full Text] [Related]  

  • 34. A mathematical model for the quantitation of tumor and antibody-forming cell populations within an animal's body.
    Hiramoto RN; Ghanta VK; McGhee JR; Hamlin NM
    J Immunol; 1973 Nov; 111(5):1546-53. PubMed ID: 4583078
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins.
    Sirisinha S; Eisen HN
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3130-5. PubMed ID: 4108872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A search for hapten-binding mouse plasmacytoma proteins.
    Mäkela O; Kaartinen M; Karjalainen K; Morse HC; Weigert M; Potter M
    Eur J Immunol; 1979 Feb; 9(2):125-9. PubMed ID: 436927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1441-8. PubMed ID: 15034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive immunity to murine plasmacytoma by rabbit antiidiotypic antibody to myeloma protein.
    Chen Y; Yakulis V; Heller P
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):121-5. PubMed ID: 1250837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to liposomal model membranes: restricted IgM and IgG anti-dinitrophenyl antibodies produced in guinea pigs.
    Uemura K; Claflin JL; Davie JM; Kinsky SC
    J Immunol; 1975 Mar; 114(3):958-61. PubMed ID: 1089729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.